-
U.S. stock market changes! Many Chinese pharmaceutical stocks such as Wanchun Pharmaceutical and Hutchison Pharmaceutical rose
Time of Update: 2022-12-29
The stock is a clinical-stage global biotechnology company that landed on the NASDAQ market in 2017 and its share price reached $48.
The stock is a clinical-stage global biotechnology company that landed on the NASDAQ market in 2017 and its share price reached $48.
-
Chinese medicine stocks that won two consecutive boards, and the stock price rose rapidly on November 14
Time of Update: 2022-12-04
For the reasons for the change in the stock, the analysis believes that it is mainly affected by three factors, including traditional Chinese medicine, industrial hemp, high-end generic drugs and other conceptual factors.
-
The market size of the domestic pharmaceutical packaging industry has exceeded 100 billion, and the future growth is high
Time of Update: 2022-12-04
For example, in the field of pharmaceutical glass, at present, China is still dominated by soda-lime glass and low borosilicate glass, with the promotion of policies such as consistency evaluation, the safety requirements of the pharmaceutical industry continue to improve, and it is expected that the proportion of domestic borosilicate glass will continue to increase in the future, and the market space is huge.
-
Under the boom of pharmaceutical companies in AI pharmaceuticals, these problems need to be solved urgently!
Time of Update: 2022-12-04
Domestic AI pharmaceuticals are hot, but these problems still need to be solved On the whole, although China's AI pharmaceutical field started late, in recent years, thanks to the encouragement of macro policies for AI technology and innovative drug research and development, as well as the rapid development of the AI field and the continuous attention of the capital market, China's AI pharmaceutical field space is gradually opening.
-
Canadian officials: Canada is facing the threat of three respiratory infections
Time of Update: 2022-11-26
According to the Canadian government, as of November 5, the national influenza virus positive detection rate in Canada reached 11.
According to the Canadian government, as of November 5, the national influenza virus positive detection rate in Canada reached 11.
-
The National Health Commission issued a Q&A on the interpretation of optimized epidemic prevention and control measures
Time of Update: 2022-11-26
Today (November 13), the National Health Commission issued the "Notice on Further Optimizing the Prevention and Control Measures of the New Crown Pneumonia Epidemic and Scientifically and Accurately Doing a Good Job in Prevention and Control", which gave a detailed interpretation of the background, optimization and adjustment of the Notice.
-
Announcement of the State Food and Drug Administration on the approval and registration of 204 medical device products
Time of Update: 2022-11-26
, Ltd National Arms Note 20223141441 138 Single-use high-pressure contrast syringes and accessories Shenzhen Yixinda Medical New Technology Co.
, Ltd National Arms Note 20223141441 138 Single-use high-pressure contrast syringes and accessories Shenzhen Yixinda Medical New Technology Co.
-
These 78 drugs and 4 high-value consumables are calculated separately for DRG points
Time of Update: 2022-11-26
js?cdnversion='+~(-new Date()/36e5)];Recently, the three departments of Foshan Municipal Medical Insurance Bureau, Health Bureau and Social Security Bureau of Guangdong Province jointly issued a notice to make corresponding arrangements for the city's inpatient medical expenses in 2022 according to DRG payment and the fixed settlement of employee maternity insurance inpatient groups.
-
The pharmaceutical business sector rose sharply, and many stocks such as Kaikai Industrial rose to the limit
Time of Update: 2022-11-26
【Pharmaceutical Network Pharmaceutical Stock Market】On November 17, the pharmaceutical business sector rose sharply, individual stocks, at 10:40, Kaikai Industry, First Pharmaceutical, Shuyu Civilian
-
Industry: Pharmaceutical companies' innovation and R&D should be patient-centered and pay attention to clinical value
Time of Update: 2022-11-26
For domestic innovative drugs, with the advancement of the new medical reform policy, the competitive environment is fierce, pharmaceutical companies generally face multiple challenges, in order to seek more markets, going overseas has become a general trend.
-
Announcement of the State Food and Drug Administration on the revision of the instructions for resorcinol injection
Time of Update: 2022-11-26
js?cdnversion='+~(-new Date()/36e5)];According to the results of the assessment of adverse drug reactions, in order to further protect the safety of public medication, the State Medical Products Administration decided to uniformly revise the contents of the instructions for resorcinol injection (including resorcinol injection and resorcinol for injection).
-
Top 20 proprietary Chinese medicines! 12 exclusive varieties dominate the screen, and 5 major brands rise by more than 10%
Time of Update: 2022-11-26
com, the sales scale of terminal proprietary Chinese medicines in public hospitals in key cities in 2022H1 exceeded 15 billion yuan, and Beijing led the sales scale; Drugs for cardiovascular and cerebrovascular diseases were the first best-selling category, and dermatology drugs and qi and blood supplements all increased by more than 15%.
-
Anti-corruption in and out of the hospital to welcome the year-end exam! A new round of crackdowns begins
Time of Update: 2022-11-26
2022 is coming to an end, and the pharmaceutical anti-corruption blows a dense clarion call! Recently, the Shanghai Municipal Health Commission and other eight departments jointly issued the "Notice
-
The diagnostic criteria for hypertension have been adjusted, and the medical equipment sector has risen significantly!
Time of Update: 2022-11-26
The company also said that it has invested research and development expenses in the production of a number of electronic blood pressure monitor products in the new series to increase the competitiveness of blood pressure monitor products in online and offline overseas markets.
-
Although the east wind of policy is blowing frequently, the medical device sector also needs to be rationally laid out
Time of Update: 2022-11-26
46 billion yuan), was also listed on August 31 this year as the fifth set of standard head stocks on the science and technology innovation board of medical devices.
-
The Anhui Provincial Commission for Discipline Inspection and Supervision has strengthened supervision and promoted the reform of centralized procurement of medicine, and accelerated the expansion of coverage
Time of Update: 2022-11-26
The report pointed out that it is necessary to put the protection of people's health in a strategic position of priority development and improve people's health promotion policies. The Anhui Provinci
-
Under the continuous improvement of pharmaceutical demand, drying equipment companies are "facing difficulties"
Time of Update: 2022-11-26
, for drying equipment enterprises, only by facing difficulties, for the current users' pain points, difficulties continue to tackle, to create more in line with market demand equipment, in order to better help the traditional Chinese medicine industry accelerate the high-quality development.
-
China's medical and health industry has entered a rational development cycle and has made steady progress in subdivided fields
Time of Update: 2022-11-26
js?cdnversion='+~(-new Date()/36e5)];At the 5th China International Import Expo, Helion, which appeared for the first time as an independent consumer health company, released the research report "Helion's Economic Contribution to China in 2021" by Oxford Economics.
-
"No profit" is also to be sold, and a large number of individual pharmacies join the collective procurement
Time of Update: 2022-11-26
According to the semi-annual report of Shuyu Civilian, as of the end of June 2022, it has opened 57 designated specialty pharmacies for serious diseases, more than 270 hospital-side stores, and 8 pharmacies that meet the standards in Shandong Province, and its DTP pharmacy sales including tax exceeded 570 million yuan, a year-on-year increase of 84.
-
Sampling in the pharmaceutical industry has become normalized, how should relevant enterprises respond?
Time of Update: 2022-11-26
(Image source: Pharmaceutical Network) Frequent pharmaceutical sampling inspections in various places, a large number of enterprises and products were notified On November 7, the Zhejiang Provincial Food and Drug Administration issued the second phase of drug quality sampling inspection in 2022.
